Lars Mecklenburg

Part of Laboratory Corp. of America Holdings, Labcorp Early Development Services GmbH is a contract research organization (CRO) that provides drug development services with the goal of advancing health. The company is based in Muenster, Germany. Labcorp Early Development Services offers thousands of in vitro tests and in vivo studies in various disciplines such as toxicology, metabolism, pharmacology, pharmacometric modeling, custom antibodies, vaccine development, infusion, inhalation, ocular, as well as disease models for oncology and cardiovascular. The German company provides SEND 3.1 datasets on the same day as the final report and can customize studies based on development milestones. With facilities worldwide, Labcorp Early Development Services helps pharmaceutical and biotechnology companies reach their development milestones more quickly and efficiently. The company's mission is to improve health and improve lives. Founded in 1981, the CEOs of the company are Glenn Andrew Eisenberg, Lars Mecklenburg, and Robert Stewart Pringle.

Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany.